CDSCO

Partners with Cipla for pan-India distribution

Lilly is working with the Indian government to provide baricitinib donations in conjunction with the permission

MoHF&W has said that the ready-to-use imported COVID vaccine would be allowed to be utilised entirely in the…

Pre-clinical data have shown that Molnupiravir has broad anti-influenza activity, including highly potent inhibition of SARS-CoV-2…

MKP10241 is a potent and orally administered small molecule, GPR119 agonist.

The DCGI will take a final call on the recommendation. If approved, it will be the third COVID-19 vaccine to be available in India

India has indicated that any vaccine maker must conduct such a trial for a shot to be considered for its immunisation programme

Action is taken based on the grievances received by the CDSCO

Pfizer withdrew an application last month seeking EUA for its product in India after the DCGI declined its request to skip a small…

Brexit is finally a reality and though India Pharma Inc expects some glitches in the short-term, it is optimistic about its impact…